 Field of Expertise |
|
Tropical Medicine |
|
Clinical studies (Phase I, II,III Drug Trials ) of Tropical Diseases eg. Cryptococcal meningitis in AIDS; oral candidiasis, Chinese herbal medicine for AIDS. |
|
Vaccine Trials(Phase I, II, III) of HIV/AIDS vaccine, Human Papilloma Virus vaccine against cervical cancer, Cholera oral vaccine, Shigella vaccine, Rota virus vaccine, Varicella vaccine, Measle vaccine etc. |
| |
|
| Memberships |
| |
Royal College of Physician of Thailand. |
| |
Medical Association of Thailand. |
| |
Thai Medical Council. |
| |
Parasitology and Tropical Medicine Association of Thailand. |
| |
Thai Medical Women’s Association. |
| |
Thai Medical Society for the Study of Sexually Transmitted Diseases. |
| |
International AIDS Society. |
| |
International Infectious Disease Society. |
| |
|
|
| Research Activities |
| |
2011 - ongoing |
Phase I safety and immunogenicity of live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 (H5N2) in healthy Thais volunteers |
| |
2011 - ongoing |
Randomized, Double Blind Evaluation of Late Boost Strategies for HIV-uninfected Participants in the HIV Vaccine Efficacy Trial RV144: “Aventis Pasteur Live Recombinant ALVAC-HIV (vCP1521) Priming with VaxGen gp120 B/E (AIDSVAXÒ B/E) Boosting in HIV-uninfected Thai Adults |
| |
2011 - ongoing |
Efficacy and safety of a novel Tetravalent Dengue vaccine in healthy children aged 2 to 14 years in Asia |
| |
2011 - ongoing |
Bioequivalence study of Warfarin 5 mg tablet in healthy Thai volunteers |
| |
2010 - 2011 |
Prospective surveillance of febrile illness for dengue-endemic areas in Asia |
| |
2009 - 2011 |
Phase I/II safety and immunogenicity of pandemic live attenuated influenza vaccine (PLAIV) candidate strain A/17/CA/2009/38 (H1N1) in healthy Thais |
| |
2009 - ongoing |
A Phase III Clinical Trial to Study the Immunogenicity, Tolerability, and Manufacturing Consistency of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (9 to 15 year olds) with a Comparison to Young Women (16 to 26 year olds) |
| |
2008 - 2009 |
A bioequivalence study of two formulations of 16 mg Candesartan tablets in healthy Thai volunteers |
| |
2008 - 2009 |
Measurement of Anogenital Wart Burden and Cost of Illnesses in Thailand |
| |
2008 - 2009 |
A Phase 2b/3, randomized, double blind, dose confirming study of the safety, efficacy and tolerability of apricitabine versus lamivudine in treatment-experienced HIV-1 infected patients with the M184V mutation in reverse transcriptase. |
| |
2007 - 2009 |
Measuring Herpes Zoster and Post-Herpetic Neuralgia Associated Burden of Illness and Health Care Utilcation and Costs in Thailand |
| |
2007 - 2008 |
Assessing the psychosocial burden in women with an abnormal pap results after screening interventions. |
| |
2006 - ongoing |
Establishment of a Shigella sonnei Challenge Model for Evaluation of Future Vaccine Candidates |
| |
2005 - ongoing |
A study to evaluate the efficacy of GARDASILTM (Human Papillomavirus [types 6,11,16,18] recombinanat vaccine) in reducing the incidence of HPV 6-,11-,16-, and 18- related CIN, AIS, and cervical cancer, and HPV 6-,11-,16-, and 18-related external genital warts, VIN, VaIN, vulvar cancer, and vaginal cancer in 26- to- 45 year-old women |
| |
2003 - 2006 |
A cross-sectional study to screen for and generate broady neutralizing monoclonal antibodies from HIV infected individuals. |
| |
2003 – ongoing |
Phase III HIV – 1 Preventive Vaccine Trial, “A Phase III Trial of Aventis Pasteur Live Recombinant ALVAC- HIV (vCP 1521) Priming with Vaxgen gp120 B/E (AIDSVAX® B/E) Boosting in HIV- un infected Thai Adults”. |
| |
2002 - 2008 |
A World-wide Phase I, Dose-escalating Study of the Safety, Tolerability and Immunogenicity of a 3-Dose Regimen of the MRKAd 5 HIV-1 gag Vaccine in healthy adults. |
| |
2002 - 2007 |
A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASILTM, Tolerability, Immunogenicity, and Efficacy Study of a Second Generation Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16-to-26-Year-Old Women |
| |
2001 - 2003 |
Safety and Therapeutic Effects of Jin Huang Chinese Medicine in Uncomplicated HIV – 1 Patients. |
| |
2001 - 2002 |
Open-Label, Treatment Protocol for the Safety and Efficacy of SCH 56592 (Oral Suspension) in the Treatment of Invasive Fungal Infections. |
| |
2001 - 2002 |
Observational Probe Study of In Vitro Immune Response Parameters to Candidate HIV – 1 Vaccine Antigens among Subjects in Thailand. |
| |
2001 - 2002 |
A Retrospective Study to Establish a Historical Database on the Efficacy of Standard Antifungal Therapy in Patients with Invasive Fungal Infection. |
| |
2000 - 2004 |
A Phase III Trial to Determine the Efficacy of AIDSVAXTM B/E Vaccine in IVDUs in Bangkok, Thailand. |
| |
2000 - 2003 |
A multicenter, randomized, double-blind, phase II study to evaluate the safety, tolerance and efficacy of multiple doses of SCH 56592 versus fluconazole in the treatment of oropharyngeal candidiasis (OPC) in HIV-positive patients |
| |
2000 - 2002 |
Phase I/II trial of Pasteur Merieux Connaught (PMC) live recombinant ALVAC – HIV (vCP1521) Priming with Vaxgen gp 120 B/E (AIDSV AXTM B/E) Boost in Thai HIV – Seronegative Adults. |
| |
1999 – 2000 |
Cholera Challenge in volunteers using frozen V. cholera 0139 bacteria for challenge |
| |
1998 – 2000 |
A Phase I/II Double-blind, Placebo-controlled study of the Chiron Biocine HIV Thai E gp 120/MF 59 Vaccine Administered alone or combined with The Chiron Biocine HIV SF 2 gp 120 Antigen in healthy HIV-seronegative Thai Adults |
| |
|
|
